DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive neoplasm with very poor patient survival outcomes despite available treatments. There is an urgent need for new potential treatment options and novel biomarkers for these patients. Delta-like canonical Notch ligand 3 (DLL3) interacts with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacalle-Gonzalez, Carlos, Florez-Cespedes, Maria, Sanz-Criado, Lara, Ochieng’ Otieno, Michael, Ramos-Muñoz, Edurne, Fernandez-Aceñero, Maria Jesus, Ortega-Medina, Luis, Garcia-Foncillas, Jesus, Martinez-Useros, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604228/
https://www.ncbi.nlm.nih.gov/pubmed/37893184
http://dx.doi.org/10.3390/biomedicines11102812

Ejemplares similares

Ejemplares similares